Vardenafil (Levitra/Staxyn) Regret, Stopping, and Restarting: What Real Users and Clinical Data Actually Show

Why Men Regret Starting Vardenafil

Most regret reported on forums like Reddit's r/erectiledysfunction and Drugs.com centers on two themes: unexpected side effects and misunderstood mechanism. Vardenafil does not produce an erection on its own. It inhibits PDE5, prolonging cGMP-mediated smooth muscle relaxation in the corpus cavernosum, but only in the presence of sexual stimulation. [1] Men who took a tablet and waited passively reported feeling "nothing happened," leading to disappointment that reads as regret but is actually a dosing or expectation problem.

The Pharmacology Behind Unmet Expectations

Vardenafil's selectivity for PDE5 over PDE6 is roughly 15-fold higher than sildenafil's, which should theoretically reduce the visual disturbances sometimes seen with sildenafil. [2] However, PDE5 inhibition still does not override an absent libido or psychogenic inhibition. A 2004 meta-analysis published in the BJU International (PMID 15298680) found that approximately 20 to 30% of men with organic ED did not achieve satisfactory intercourse even at maximum doses across PDE5 inhibitor trials, underlining that the drug is not universally effective. [3]

Side Effects That Drive Early Discontinuation

The FDA-approved prescribing information for Levitra lists the following adverse reactions occurring in more than 2% of patients in placebo-controlled trials: headache (15%), flushing (11%), rhinitis (9%), dyspepsia (4%), sinusitis (3%), and flu syndrome (3%). [4] On Drugs.com, user reviews frequently flag the headache and flushing as "not worth it" at 20 mg, but the same users who dropped to 10 mg or 5 mg often reported the side effects became manageable. Taking the tablet with a light meal (not a high-fat meal, which delays absorption by up to 60 minutes) also reduced gastrointestinal complaints in anecdotal accounts. [4]

The rare but serious side effect of sudden hearing loss carries an FDA black-box-adjacent warning. [4] Priapism, defined as an erection lasting more than four hours, is infrequent but constitutes a urological emergency and is cited in forum posts as causing significant anxiety that led users to stop the drug permanently.

Who Actually Quits and Who Restarts

Stopping vardenafil is common. A 2005 observational study in the journal Urology (PMID 15780425) tracked 1,189 men on PDE5 inhibitors across six countries and found that 46% discontinued within 12 months, with inadequate efficacy (29%) and adverse events (18%) as the leading reasons. [5] That same study noted that men who received structured counseling about proper use had significantly lower discontinuation rates, which maps directly onto what forum users describe: men who understood timing, stimulation requirements, and dose titration stuck with the drug.

The "I Tried It Once and It Didn't Work" Pattern

Reddit threads in r/erectiledysfunction consistently surface a pattern where a man takes 10 mg on a high-stress night, gets no erection, and concludes the drug failed. What actually happened is a confluence of anxiety-driven sympathetic tone, possibly a high-fat meal, and no sustained stimulation. Sympathetic nervous system activation is a known physiological antagonist to the nitric-oxide pathway vardenafil depends on. [1] A single failed attempt at an unoptimized dose does not constitute a fair clinical trial of the drug.

Who Is Most Likely to Restart Successfully

Men who restart vardenafil after a break tend to succeed when they address the root cause of their first failure. The Phase III registration trial for Levitra (PMID 12050513) enrolled 805 men across multiple ED etiologies and found that 71% of attempts resulted in successful intercourse at 10 mg and 75% at 20 mg, versus 52% on placebo. [6] Men with diabetes-related ED showed lower but still meaningful response rates: approximately 57% at 20 mg versus 23% on placebo in the diabetic subgroup analysis. [6] These data suggest that restarting with a clear protocol, meaning the correct dose, proper timing, and sexual stimulation, gives most men a reasonable probability of success.

What Reddit and Drugs.com Reviews Actually Report

Synthesizing forum data requires acknowledging the obvious bias: men who had uneventful, positive experiences rarely post. Still, patterns across hundreds of posts and Drugs.com ratings (average 7.3/10 across approximately 900 reviews as of mid-2025) reveal actionable themes.

Positive Themes in User Reports

Users who report satisfaction consistently describe vardenafil as "more forgiving" than sildenafil regarding the meal-timing interaction, though this perception is partially inaccurate since high-fat meals still reduce peak plasma concentration (Cmax) by 18 to 50%. [4] The 25-minute onset is cited favorably versus the 30 to 60-minute window sometimes required for sildenafil. Staxyn's orally disintegrating formulation receives particular praise for discretion and convenience, though its bioavailability is not bioequivalent to the Levitra tablet and should not be used interchangeably on a milligram basis. [4]

Negative Themes and Regret Patterns

The most common negative reviews fall into three groups. First, men who experienced a prolonged headache at 20 mg and never tried a lower dose. Second, men who were also taking alpha-blockers (such as tamsulosin for benign prostatic hyperplasia) who experienced symptomatic hypotension, a known pharmacodynamic interaction requiring either dose separation of at least six hours or using the lowest vardenafil dose (5 mg). [4] Third, men in relationships where the partner felt the medicated erection was "mechanical" or changed the emotional dynamic, a psychosocial dimension that no dose adjustment addresses. [7]

The Clinical Decision Framework for Restarting After a Break

Restarting vardenafil is not simply taking the same pill again. A structured approach reduces the chance of a second discontinuation.

Step 1: Rule Out Contraindications Before Restarting

The absolute contraindications to vardenafil have not changed since 2003. [4] They include:

• Any nitrate medication in any form (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, amyl nitrite). The resulting hypotension can be fatal.
• Concomitant use of a potent CYP3A4 inhibitor such as ketoconazole 400 mg daily or ritonavir, which raises vardenafil plasma concentration by 49-fold and 13-fold respectively. [4]
• Severe hepatic impairment (Child-Pugh C), where clearance is dramatically reduced.
• Hereditary degenerative retinal disorders including retinitis pigmentosa.

Men who developed new cardiovascular disease during their time off vardenafil should complete a cardiovascular risk assessment before restarting. The Princeton III Consensus, published in the American Journal of Cardiology in 2012, provides a three-tier risk stratification framework for sexual activity and PDE5 inhibitor use in cardiac patients. [8]

Step 2: Correct the Dosing Variables

Most forum-reported failures involve at least one of these modifiable factors:

1. Taking the tablet with a high-fat meal (delays Tmax by approximately 60 minutes and reduces Cmax). [4]
2. Attempting intercourse before the drug has reached adequate plasma concentration (waiting at least 25 to 30 minutes is the minimum; 60 minutes is more reliable for some men). [4]
3. Starting at 20 mg rather than titrating up from 10 mg, which increases side effect burden without guaranteeing better efficacy for all men.
4. Expecting the drug to produce erections without adequate sexual stimulation.

Step 3: Give the Restart a Fair Trial

The International Index of Erectile Function (IIEF) domain scoring used in clinical trials defines a meaningful response as improvement in the erectile function domain score of at least 4 points over baseline. [9] Men in the Levitra registration trial used the drug for 12 weeks before efficacy was formally assessed. A single attempt is not a fair test. Clinicians typically recommend at least six to eight attempts before declaring a dose ineffective.

Vardenafil vs. Other PDE5 Inhibitors: Switching After Regret

Men who regret vardenafil sometimes switch to tadalafil (Cialis) for its 36-hour window, which removes time pressure, or to sildenafil (Viagra) because of familiarity. A 2009 crossover study published in the Journal of Sexual Medicine (PMID 19563500) found that men who switched PDE5 inhibitors after dissatisfaction with their first agent had improved satisfaction scores in 64% of cases, suggesting that individual pharmacodynamic differences matter. [10]

When Tadalafil Makes More Clinical Sense

Tadalafil's longer half-life (17.5 hours versus vardenafil's 4 to 5 hours) suits men who find the timed dosing of vardenafil anxiety-provoking. Tadalafil 5 mg once daily is FDA-approved for daily use, eliminating anticipatory dosing entirely. [11] For men whose primary regret about vardenafil was the narrow timing window, daily tadalafil is a reasonable next step after a clinician evaluation.

When Staying on Vardenafil Makes Sense

Vardenafil's PDE5 selectivity profile makes it a reasonable choice for men who experienced color vision changes on sildenafil. [2] The orodispersible Staxyn formulation suits men with swallowing difficulties. Men who respond well at 10 mg with manageable side effects have no clinical reason to switch.

Does Vardenafil Work for Everyone?

No PDE5 inhibitor works for everyone. The non-response rate across PDE5 inhibitors is approximately 20 to 35% in unselected erectile dysfunction populations. [3] Men with severe arterial insufficiency, radical prostatectomy with bilateral neurovascular bundle sacrifice, or poorly controlled diabetes have lower response rates. The 2012 EAU Guidelines on Male Sexual Dysfunction note that total testosterone levels below 300 ng/dL reduce PDE5 inhibitor efficacy, and treating hypogonadism concurrently improves response rates. [12] A testosterone level should be checked before labeling any man a "PDE5 inhibitor non-responder."

Predictors of Poor Response

• Bilateral nerve-sparing status not preserved during prostatectomy. [12]
• Hemoglobin A1c above 9% (poorly controlled diabetes impairs endothelial NO synthesis). [13]
• Severe penile arterial disease confirmed on duplex Doppler ultrasound (peak systolic velocity <25 cm/s). [12]
• Untreated hypogonadism (total testosterone <300 ng/dL). [12]

Predictors of Good Response After Restarting

• Psychogenic or mixed-etiology ED rather than purely arteriogenic. [3]
• Testosterone in the normal range. [12]
• Absence of confounding medications (SSRIs, antihypertensives, antipsychotics). [7]
• Partner involvement and reduced performance anxiety. [7]

Vardenafil and Long-Term Use: Safety Signals to Know

Long-term vardenafil use does not appear to produce tachyphylaxis (loss of effect requiring increasing doses) based on available data. A 2-year open-label extension study of vardenafil (PMID 15879779) found no significant loss of efficacy over time and no new safety signals beyond those identified in Phase III trials. [14] Cardiovascular mortality was not increased relative to age-matched controls not using PDE5 inhibitors in observational data, a finding consistent with the vasodilatory mechanism posing minimal risk in men without nitrate use. [8]

Non-arteritic anterior ischemic optic neuropathy (NAION), a condition causing sudden vision loss, has been reported with all PDE5 inhibitors in post-marketing surveillance. The absolute risk is very low, but men with a history of NAION in one eye should not restart vardenafil. [4]

What Stopping Vardenafil Does to Erectile Function

Vardenafil has no pharmacological withdrawal syndrome. Stopping the drug does not worsen baseline erectile function below pre-treatment levels. [4] However, men who relied on vardenafil to manage performance anxiety may experience a psychological rebound when they stop, reporting anxiety-driven ED that feels worse than before they started. This is a behavioral pattern, not a drug effect. Referral to a sex therapist or psychologist experienced in sexual medicine is appropriate for this group. [7]

Some emerging data suggest that daily low-dose PDE5 inhibitor use may have a mild rehabilitative effect on penile smooth muscle oxygenation, particularly after prostatectomy, but this remains an area of active investigation rather than established standard of care. [15]